叫我小张就好
Lv1
60 积分
2021-03-05 加入
-
Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial
3个月前
已完结
-
A Phase III, Randomized, Multi-Center, Open-Label, Fixed Dose, Neulasta Active-Controlled Clinical Trial of F-627, a Novel G-CSF, in Women with Breast Cancer Receiving Myelotoxic Chemotherapy
3个月前
已关闭
-
Perioperative Nivolumab and Chemotherapy in Stage III Non–Small-Cell Lung Cancer
4个月前
已完结
-
Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial
4个月前
已完结
-
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial
4个月前
已完结
-
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
6个月前
已完结
-
Sugemalimab versus placebo, in combination with platinum-based chemother.apy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): Interim and final analyses ofa double-blind, randomised, phase 3 clinical trial
6个月前
已完结
-
《食管癌肝转移诊断和治疗现状》
7个月前
已关闭
-
探索紫杉醇脂质体与奈达铂在晚期食管癌的临床疗效及联合卡瑞利珠单抗和阿帕替尼四药治疗过程中发生肝功能异常的临床特点
7个月前
已完结
-
干扰素联合抗病毒治疗对提高核苷(酸)类药物经治慢性乙型肝炎患者表面抗原阴转率的影响
8个月前
已关闭